Protein kinase C-β inhibition attenuates the progression of nephropathy in non-diabetic kidney disease

Nephrology Dialysis Transplantation

Volumn 24, Issue 6, 2009, Pages 1782-1790

  Kelly, Darren J ^a   Edgley, Amanda J ^a   Zhang, Yuan ^a   Thai, Kerri ^b   Tan, Sih Min ^a   Cox, Alison J ^a   Advani, Andrew ^b   Connelly, Kim A ^b   Whiteside, Catharine I ^c   Gilbert, Richard E ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Glomerulosclerosis; Nephrin; Protein kinase C; Proteinuria; Tubulointerstitial fibrosis

Indexed keywords

NEPHRIN; RUBOXISTAURIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MECHANISM; EXPERIMENTAL MODEL; FIBROSING ALVEOLITIS; GENE EXPRESSION REGULATION; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HYPERTENSION; KIDNEY DISEASE; MALE; NEPHRECTOMY; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; RAT;

ANIMALS; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GLOMERULAR FILTRATION RATE; HUMANS; INDOLES; KIDNEY; KIDNEY DISEASES; MALE; MALEIMIDES; MEMBRANE PROTEINS; MESANGIAL CELLS; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 67651115799     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn729     Document Type: Article

References (37)

1. Ritz E, Rychlik I, Locatelli F et al. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 1999; 34: 795-808
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820
3. Goekjian PG, Jirousek MR. Protein kinase C in the treatment of disease: signal transduction pathways, inhibitors, and agents in development. Curr Med Chem 1999; 6: 877-903
4. Tuttle KR, Bakris GL, Toto RD et al. The effect of ruboxistaurin on nephropathy in type 2 diabetes. Diabetes Care 2005; 28: 2686-2690
5. Saxena R, Saksa BA, Hawkins KS et al. Protein kinase C beta I and beta II are differentially expressed in the developing glomerulus. Faseb J 1994; 8: 646-653
6. Ganz MB, Abunader R, Saxena R et al. Protein kinase C beta(Ii) isoform is up-regulated in human proliferative glomerulonephritis. Exp Nephrol 1997; 5: 225-232
7. Feng X, Zhang J, Barak LS et al. Visualization of dynamic trafficking of a protein kinase C betaII/green fluorescent protein conjugate reveals differences in G protein-coupled receptor activation and desensitization. JBiolChem 1998; 273: 10755-10762
8. Ganz MB, Saksa B, Saxena R et al. Pdgf and Il-1 induce and activate specific protein kinase C isoforms in mesangial cells. Am J Physiol Renal Fluid Electrolyte Physiol 1996; 40: F108-F113
9. Fujita T, Asai T, Andrassy M et al. PKCbeta regulates ischemia/reperfusion injury in the lung. J Clin Invest 2004; 113: 1615-1623
10. Boyle AJ, Kelly DJ, Zhang Y et al. Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction. J Mol Cell Cardiol 2005; 39: 213-221
11. Wu L, Cox A, Roe C et al. Transforming growth factor ß1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system. Kidney Int 1997; 51: 1553-1567
12. Bidani AK, Griffin KA, Bakris G et al. Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation. Kidney Int 2000; 57: 1651-1661
13. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993-2000
14. Bunag RD. Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol 1973; 34: 279-282
15. Advani A, Kelly DJ, Advani SL et al. Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions. Proc Natl Acad Sci USA 2007; 104: 14448-14453
16. Kakizaki Y, Kraft N, Atkins RC. Differential control of mesangial cell proliferation by interferon-gamma. Clin Exp Immunol 1991; 85: 157-163
17. Villarreal FJ, Kim NN, Ungab GD et al. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 1993; 88: 2849-2861
18. Bergman I, Loxley R. New spectrophotometric method for the determination of proline in tissue hydrolyzates. Anal Chem 1970; 42: 702-706
19. Kelly DJ, Aaltonen P, Cox AJ et al. Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies. Nephrol Dial Transplant 2002; 17: 1327-1332
20. Gilbert RE, Wu LL, Kelly DJ et al. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy - implications for the pathogenesis of tubulointerstitial fibrosis. Am J Pathol 1999; 155: 429-440
21. 33P. J Histochem Cytochem 1993; 41: 1767-1773
22. Cooper ME, Vranes D, Youssef S et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 1999; 48: 2229-2239
23. Newton AC. Protein kinase C: structure, function, and regulation. JBiolChem 1995; 270: 28495-28498
24. Babazono T, Kapor-Drezgic J, Dlugosz JA et al. Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. Diabetes 1998; 47: 668-676
25. Kapor-Drezgic J, Zhou X, Babazono T et al. Effect of high glucose on mesangial cell protein kinase C-delta and - epsilon is polyol pathway-dependent. J Am Soc Nephrol 1999; 10: 1193-1203
26. Xia L, Wang H, Munk S et al. Reactive oxygen species, PKC-β1, and PKC-zeta mediate high-glucose-induced vascular endothelial growth factor expression in mesangial cells. Am J Physiol Endocrinol Metab 2007; 293: E1280-E1288
27. Ishii H, Jirousek MR, Koya D et al. Amelioration of vascular dysfunction in diabetic rats by an oral PKC ß inhibitor. Science 1996; 272: 728-731
28. Meier M, Park JK, Overheu D et al. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model. Diabetes 2007; 56: 346-354
29. Cejas PJ, Carlson LM, Zhang J et al. Protein kinase C betaII plays an essential role in dendritic cell differentiation and autoregulates its own expression. JBiolChem 2005; 280: 28412-28423
30. Liu Y, Su W, Thompson EA et al. Protein kinase CbetaII regulates its own expression in rat intestinal epithelial cells and the colonic epithelium in vivo. JBiolChem 2004; 279: 45556-45563
31. Langham RG, Kelly DJ, Gow RM et al. Increased renal gene transcription of protein kinase C-beta in human diabetic nephropathy: relationship to long-term glycaemic control. Diabetologia 2008; 51: 668-674
32. Tryggvason K. Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm. J Am Soc Nephrol 1999; 10: 2440-2445
33. Langham RG, Kelly DJ, Cox AJ et al. Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia 2002; 45: 1572-1576
34. Kim BK, Hong HK, Kim JH et al. Differential expression of nephrin in acquired human proteinuric diseases. Am J Kidney Dis 2002; 40: 964-973
35. Prud' homme GJ. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest 2007; 87: 1077-1091
36. Ruiz-Ortega M, Rodriguez-Vita J, Sanchez-Lopez E et al. TGF-beta signaling in vascular fibrosis. Cardiovasc Res 2007; 74: 196-206
37. Mishra R, Zhu L, Eckert RL et al. TGF-beta-regulated collagen type I accumulation: role of Src-based signals. Am J Physiol Cell Physiol 2007; 292: C1361-C1369